Moderna COVID-19 antibody shows 94.1% adequacy in preliminary: Study Kumar Jeetendra | December 31, 2020 Results from the primary analysis of the ongoing phase 3 clinical trial of US biotechnology company Moderna’s COVID-19 vaccine have revealed 94.1 per cent effectiveness of the therapeutic in preventing symptomatic infections and severe illness, according to a peer-reviewed study. The analysis, published on Wednesday in The New England Journal of Medicine, found that among …
Poisonous pesticide transformed into treatment against antibiotic-resistant bacteria Kumar Jeetendra | December 30, 2020 They are used as pesticides and fungicides. However, these substances could be poisonous to humans and cause mutations. As they aren’t frequently used, there’s little data about them in the medicinal chemistry literature. However, it has been suggested recently that the groups of substances that are traditionally avoided can help to fight pathogenic bacteria. Yet, …
Will COVID-19 immunizations work on the new Covid variant? Kumar Jeetendra | December 30, 2020 Germany | Germans enjoyed a mostly relaxed summer with several restrictions increased, the dividend of a quick response to the initial coronavirus outbreak and a dependence on early and widespread testing that won wide praise. It brought the amount of daily COVID-19 cases down from a peak of more than 6,000 in late March to …
Enormous transporter protein dysfunction related with schizophrenia Kumar Jeetendra | December 29, 2020 Researchers have suspected mutations in a cellular cholesterol transport protein are associated with psychiatric disorders, but have found it hard to show this and to pinpoint how it happens. Currently, Kazumitsu Ueda of Kyoto University’s Institute for Integrated Cell-Material Sciences (iCeMS) and colleagues in Japan have provided evidence that mice with disrupted ABCA13 protein demonstrate …
FDA favors first conventional glucagon for injection to treat extreme hypoglycemia Kumar Jeetendra | December 29, 2020 Today, the U.S. Food and Drug Administration approved the first generic of glucagon for injection USP, 1 mg/vial packed in an emergency kit, for the treatment of severe hypoglycemia (very low blood sugar), which may occur in patients with diabetes mellitus. The drug is also indicated as a diagnostic aid in the radiologic examination of …
Six cases of new mutant corona strain detected in India Kumar Jeetendra | December 29, 2020 Six cases of a mutant strain of coronavirus that first surfaced in the united kingdom, have been discovered in the country. The new strain is believed to be 70 percent more infectious, but doctors have said there isn’t any reason yet to believe that it is more lethal or will not be controlled by means …
Britain ought to vaccinate 2 million every week to prevent 3rd COVID-19 wave: Study Kumar Jeetendra | December 29, 2020 Britain must vaccinate two million people a week to avoid a third wave of the coronavirus outbreak, a study by the London School of Hygiene and Tropical Medicine (LSHTM) has concluded. The UK has had over 71,000 deaths from the coronavirus and has recorded over 2.3 million cases of COVID-19 infections as of late Monday, …
Novavax scheduled late-stage trial of COVID-19 vaccine in United States Kumar Jeetendra | December 29, 2020 Novavax Inc has begun a large late-stage study of its experimental COVID-19 vaccine in the United States, the drug developer said on Monday, after delaying the trial twice due to issues in scaling up the manufacturing process. It will enroll up to 30,000 volunteers across about 115 sites in the United States and Mexico, with …
Coronavirus variant from South Africa detected in Japan Kumar Jeetendra | December 29, 2020 Japan on Monday detected a coronavirus version found in South Africa, the government said, the first such discovery in a state that has already identified more than a dozen cases of a different variant that is spreading rapidly in Britain. A woman in her 30s who arrived in Japan on Dec. 19 was found to …
India to Play Vital Role in Equitable Distribution of COVID-19 Vaccines: Pharma Industry Kumar Jeetendra | December 28, 2020 With vaccine rollout starting in some countries, the world ravaged by the COVID-19 pandemic is looking to India for the large-scale production and supply of coronavirus vaccines as it enters 2021. Since the pandemic hit the world in 2020, Indian pharma industry rose to the occasion and managed to fabricate and maintain supply chains even …
Scientists grow new framework for direct location of SARS-CoV-2 in aerosols Kumar Jeetendra | December 28, 2020 Researchers in the Polytechnic University of Valencia (UPV), in collaboration with specialists from the University of Valencia (UV), have produced a new system based on a high-sensitivity mass biosensor that continuously monitors signals for the immediate detection of SARS-CoV-2 in environmental aerosols. The device, in prototype stage, makes it possible to appraise the quality of …
Surgery may expand length of endurance for metastatic breast malignant growth patients Kumar Jeetendra | December 28, 2020 They studied nearly 13,000 stage four breast cancer patients and found that those who had surgery as well as their other remedies had a survival advantage over those who had other therapies alone. Stage four breast cancer accounts for 6% of newly-diagnosed breast cancer cases. Systemic treatment, which may include treatments like chemotherapy, hormone therapies …
